Entity: all
News about Bristol Myers Squibb
ShareAnalyse the news about Bristol Myers Squibb from multiple sources, get visualizations or extract the entire dataset.
Related dashboards:
- Bristol Myers Squibb (organization)
Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
J&J, Merck and Bristol Myers Squibb CEOs Defend Drug Prices at Senate Hearing
J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Stocks making the biggest moves midday: Nike, Rocket Lab, Bristol Myers, NetEase and more
Stocks making the biggest moves before the bell: Nike, Bristol Myers, NetEase, Coinbase, and more
Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial
Dataset
Extract all news on this scope:
Analysis
See the trend on this scope:
Evolution through time
Sources analysis:
Distribution of sources in the news
Sections analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive with a score of 0.31
| neutral | 47% | |
| positive | 42% | |
| negative | 11% |
Sentiment polarity through time
